Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02373520

Ligand	Ligand name	Chain	PDB	Tanimoto
GVB	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	A,B	2JID	0.76
MR1	1-(1,3-BENZODIOXOL-5-YL)METHANAMINE	A	2ORQ	0.74
BER	BERBERINE	A	3D6Y	0.71
BER	BERBERINE	A,B,D,E	1JUM	0.71
BER	BERBERINE	A,B,D,E	3BTI	0.71
BER	BERBERINE	A	2QVD	0.71
R23	METHYL-[4-(4-PIPERIDINE-1-YLMETHYL-PHENYL)-CYCLOHEXYL]-CARBAMINIC ACID-(4-CHLOROPHENYL)-ESTER	A,B,C	1O79	0.7
4CR	(1R)-4-({[ETHYL(METHYL)AMINO]CARBONYL}OXY)-N-METHYL-N-[(1E)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C65	0.74
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.71
MOI	(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL	H,L	1Q0Y	0.77
PTI	2-PHENYL-1-[4-(2-PIPERIDIN-1-YL-ETHOXY)-PHENYL]-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-6-OL	A	1UOM	0.73
AI3	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	A,C,D	1TL8	0.71
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.87
LO2	2-{4-[butyl(3-chloro-4,5-dimethoxybenzyl)amino]phenyl}-1,1,1,3,3,3-hexafluoropropan-2-ol	A,B,C,D	3FAL	0.7
ROL	ROLIPRAM	A,B,C,D	1OYN	0.71
ROL	ROLIPRAM	A,B	1XMY	0.71
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.71
ROL	ROLIPRAM	A,B	1RO6	0.71
ROL	ROLIPRAM	A,B	1XN0	0.71
ROL	ROLIPRAM	A,B	1TBB	0.71
DPD		A,B	1QIW	0.81
DPD		A	1QIV	0.81
C3D	(5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL	A	2OUZ	0.72
MDW	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	A	2DDY	0.71
GGO	(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE	B	2OQI	0.74
HWG	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	A,D	1R20	0.7
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.79
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.71
TOL	TOLRESTAT	A	2PDL	0.71
TOL	TOLRESTAT	A	2FZD	0.71
TOL	TOLRESTAT	A	2FZB	0.71
TOL	TOLRESTAT	A	1AH3	0.71
TOL	TOLRESTAT	X	1ZUA	0.71
TOL	TOLRESTAT	A	1AE4	0.71
BS1	(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE	A,F	2W8F	0.7
UIB	(1R,3AS,4R,8AS,8BR)-4-{5-(PHENYL[1,3]DIOXOL-5-YLMETHYL)-4-ETHYL-2,3,3-TRIMETHYL-6-OXO-OCTAHYDRO-PYRROLO[3,4-C]PYRROL-1-YL}-BENZAMIDINE	H,I	1YPJ	0.7
UIB	(1R,3AS,4R,8AS,8BR)-4-{5-(PHENYL[1,3]DIOXOL-5-YLMETHYL)-4-ETHYL-2,3,3-TRIMETHYL-6-OXO-OCTAHYDRO-PYRROLO[3,4-C]PYRROL-1-YL}-BENZAMIDINE	A	1Y3X	0.7
CM4	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	A	1YIM	0.71
GNT	(-)-GALANTHAMINE	A	1DX6	0.8
GNT	(-)-GALANTHAMINE	A	1QTI	0.8
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.8
GNT	(-)-GALANTHAMINE	A,B	1W76	0.8
GNT	(-)-GALANTHAMINE	A	1W6R	0.8
11N	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	A,B,C,D	2ZEC	0.76
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.73
REN	(S)-reticuline	A	3FWA	0.9
REN	(S)-reticuline	A	3D2D	0.9